http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06321792-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66a9d6f86e9d9803174d2a03d3cd24a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91ce16ac3dbceb38cb5e6983c8c15a5a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
filingDate 1993-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_574092a7787907191c76c45750e3f75c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ea61a97fb47d14ff30344e25277eaaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d097f4c9c1912290a791bf6ae503676
publicationDate 1994-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H06321792-A
titleOfInvention Side effect reducer
abstract (57) [Summary] [Object] The present invention aims to provide a side effect reducing agent by a pharmaceutical agent, and more specifically, nephrotoxicity caused by administration of a platinum complex such as cisplatin, It is an object of the present invention to provide a compound that reduces side effects such as hematological toxicity. [Structure] The present invention is to pulverize a Japanese herbal medicine (Toki, licorice, sycamore or soft purple root), or its original plant or other plants of the same genus, and extract with an aqueous solvent in an amount of about 10 times, and extract the extract. It is an agent for reducing side effects caused by a drug containing a polysaccharide component as an active ingredient, which is obtained by performing operations such as ethanol precipitation and dialysis on a filtrate obtained by filtration. By administering the above-mentioned substances together with cisplatin which is an anticancer agent, side effects can be reduced without diminishing the effect of cisplatin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1435963-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1435963-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101985965-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100501039-B1
priorityDate 1993-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441203
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID49827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID46348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15559384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413533255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID46348
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID49827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19233

Total number of triples: 44.